Login Register Cart 0
Generic placeholder image

Current Women`s Health Reviews

Editor-in-Chief

ISSN (Print): 1573-4048
ISSN (Online): 1875-6581

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Fertility Potential of Freshly Isolated Adipose Tissue-derived Stromal Cells and Bone Marrow Mesenchymal Stromal Cells in Premature Ovarian Failure

Author(s): Tahir Maqbool*, Faheem Hadi, Sehrish Tahir, Sadia Naz, Sajida Shahnawaz, Sana Javaid Awan and Arif Malik

Volume 18, Issue 1, 2022

Published on: 08 February, 2021

Article ID: e041021191233 Pages: 10

DOI: 10.2174/1573404817666210208205239

Price: $65

Abstract

Background: Failure to attain pregnancy or even miscarriage leads to a challenging type of infertility which is premature ovarian failure (POF). Stem cells have the ability to repair ovarian damage; adipose tissue-derived stromal cells (AT-SCs) and bone marrow mesenchymal stromal cells (BM-MSCs) have demonstrated promising regenerative abilities in several diseases, including POF.

Methods: Various experiments were performed to prove the ability of AT-SCs and BM-MSCs in restoring ovarian functions; a total of 20 rats were randomly selected and assigned to four experimental groups with 5 rats in each group; 1st untreated, 2nd cyclophosphamide and busulfan, 3rd cyclophosphamide and busulfan + AT-SCs, and 4th cyclophosphamide and busulfan + BM-MSCs treated.

Results: Groups 3 and 4 showed a restoration of ovarian functions in the form of an increase in weight (including body weight and ovarian weight), anti-mullerian hormone (AMH) and estradiol (E2) level, a decrease in follicle stimulating hormone (FSH) serum levels and an increase in antioxidant level of glutathione (GSH) and superoxide dismutase (SOD) in comparison with group 2. Histochemistry analysis demonstrated normal tissue distribution in the 3rd and 4th groups compared to 2nd group.

Conclusion: We demonstrated the ability of AT-SCs and BM-MSCs to restore ovarian functions in females with POF.

Keywords: POF, AT-SCs, BM-MSCs, AMH, FSH, estradiol, GSH, SOD.

Graphical Abstract

[1]
Hull MG, Glazener CM, Kelly NJ, et al. Population study of causes, treatment, and outcome of infertility. Br Med J (Clin Res Ed) 1985; 291(6510): 1693-7.
[http://dx.doi.org/10.1136/bmj.291.6510.1693] [PMID: 3935248]
[2]
Chandra A, Martinez GM, Mosher WD, Abma JC, Jones J. Fertility, family planning, and reproductive health of u.s. women: data from the 2002 national survey of family growth. Vital and health statistics series 23, data from the national survey of family growth. Vital Health Stat 23 2005; 25: 1-160.
[3]
Deroux A, Dumestre-Perard C, Dunand-Faure C, Bouillet L, Hoffmann P. Female infertility and serum auto-antibodies: a systematic review. Clin Rev Allergy Immunol 2017; 53(1): 78-86.
[http://dx.doi.org/10.1007/s12016-016-8586-z] [PMID: 27628237]
[4]
Zhao YX, Chen SR, Su PP, et al. Using mesenchymal stem cells to treat female infertility: an update on female reproductive diseases. Stem Cells Int 2019; 2019
[http://dx.doi.org/10.1155/2019/9071720] [PMID: 31885630]
[5]
Panay N, Fenton A. Premature ovarian failure: a growing concern. Climacteric 2008; 11(1): 1-3.
[http://dx.doi.org/10.1080/13697130701878635]
[6]
Zhu SF, Hu HB, Xu HY, et al. Human umbilical cord mesenchymal stem cell transplantation restores damaged ovaries. J Cell Mol Med 2015; 19(9): 2108-17.
[http://dx.doi.org/10.1111/jcmm.12571] [PMID: 25922900]
[7]
Mohamed SA, Shalaby S, Brakta S, Elam L, Elsharoud A, Al-Hendy A. Umbilical cord blood mesenchymal stem cells as an infertility treatment for chemotherapy induced premature ovarian insufficiency. Biomedicines 2019; 7(1): E7.
[http://dx.doi.org/10.3390/biomedicines7010007] [PMID: 30669278]
[8]
Nelson LM. Clinical practice. Primary ovarian insufficiency. N Engl J Med 2009; 360(6): 606-14.
[http://dx.doi.org/10.1056/NEJMcp0808697] [PMID: 19196677]
[9]
Sükür YE, Kıvançlı IB, Ozmen B. Ovarian aging and premature ovarian failure. J Turk Ger Gynecol Assoc 2014; 15(3): 190-6.
[http://dx.doi.org/10.5152/jtgga.2014.0022] [PMID: 25317048]
[10]
Lorzadeh N, Kazemirad N. Application of stem cells to infertility treatment with emphasis on mesenchymal stem cells and ovarian stem cells. Am J Perinatol 2018; 35(12): 1142-7.
[http://dx.doi.org/10.1055/s-0038-1646948] [PMID: 29715701]
[11]
Salem HK, Thiemermann C. Mesenchymal stromal cells: current understanding and clinical status. Stem Cells 2010; 28(3): 585-96.
[PMID: 19967788]
[12]
Körbling M, Anderlini P. Peripheral blood stem cell versus bone marrow allotransplantation: does the source of hematopoietic stem cells matter? Blood 2001; 98(10): 2900-8.
[http://dx.doi.org/10.1182/blood.V98.10.2900] [PMID: 11698269]
[13]
In ’t Anker PS, Scherjon SA, Kleijburg-van der Keur C, et al. Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells 2004; 22(7): 1338-45.
[http://dx.doi.org/10.1634/stemcells.2004-0058] [PMID: 15579651]
[14]
Lendeckel S, Jodicke A, Christophis P, et al. Autologous stem cells (adipose) and fibrin glue used to treat widespread traumatic calvarial defects: case report. J Craniomaxillofac Surgery 2004; 32(6): 370-.
[15]
Ra JC, Jeong EC, Kang SK, Lee SJ, Choi KHA. A prospective, nonrandomized, no placebo-controlled, phase I/II clinical trial assessing the safety and efficacy of intramuscular injection of autologous adipose tissue-derived mesenchymal stem cells in patients with severe buerger’s disease. Cell Med 2016; 9(3): 87-102.
[http://dx.doi.org/10.3727/215517916X693069] [PMID: 28713639]
[16]
Choudhery MS, Badowski M, Muise A, Pierce J, Harris DT. Donor age negatively impacts adipose tissue-derived mesenchymal stem cell expansion and differentiation. J Transl Med 2014; 12: 8.
[http://dx.doi.org/10.1186/1479-5876-12-8] [PMID: 24397850]
[17]
Chen Y, Shao JZ, Xiang LX, Dong XJ, Zhang GR. Mesenchymal stem cells: a promising candidate in regenerative medicine. Int J Biochem Cell Biol 2008; 40(5): 815-20.
[http://dx.doi.org/10.1016/j.biocel.2008.01.007] [PMID: 18295530]
[18]
Maridas DE, Rendina-Ruedy E. Isolation, culture, and differentiation of bone marrow stromal cells and osteoclast progenitors from mice. J Visualized Exp : JoVE 2018.
[19]
Wajid N, Ali A, Ali F, Latief N, Qazi A. Therapeutic potential of stem cells derived factor-1 alpha (SDF-1α) for skin burn injuries. Adv Life Sci 2019; 6(4): 139-46.
[20]
Maqbool T, Awan SJ, Malik S, Hadi F, Shehzadi S, Tariq K. In-vitro anti-proliferative, apoptotic and antioxidative activities of medicinal herb kalonji (Nigella Sativa). Curr Pharm Biotechnol 2019; 20(15): 1288-308.
[http://dx.doi.org/10.2174/1389201020666190821144633] [PMID: 31433749]
[21]
Tamadon A, Mehrabani D, Rahmanifar F, et al. Induction of spermatogenesis by bone marrow-derived mesenchymal stem cells in busulfan-induced azoospermia in hamster. Int J Stem Cells 2015; 8(2): 134-45.
[http://dx.doi.org/10.15283/ijsc.2015.8.2.134] [PMID: 26634062]
[22]
Ghasemzadeh-Hasankolaei M, Batavani R, Eslaminejad MB, Sayahpour F. Transplantation of autologous bone marrow mesenchymal stem cells into the testes of infertile male rats and new germ cell formation. Int J Stem Cells 2016; 9(2): 250-63.
[http://dx.doi.org/10.15283/ijsc16010] [PMID: 27430978]
[23]
Asgari HR, Akbari M, Yazdekhasti H, et al. Comparison of human amniotic, chorionic, and umbilical cord multipotent mesenchymal stem cells regarding their capacity for differentiation toward female germ cells. Cell Reprogram 2017; 19(1): 44-53.
[http://dx.doi.org/10.1089/cell.2016.0035] [PMID: 28112985]
[24]
Park JH, Hwang I, Hwang SH, Han H, Ha H. Human umbilical cord blood-derived mesenchymal stem cells prevent diabetic renal injury through paracrine action. Diabetes Res Clin Pract 2012; 98(3): 465-73.
[http://dx.doi.org/10.1016/j.diabres.2012.09.034] [PMID: 23026513]
[25]
Wang S, Yu L, Sun M, et al. The therapeutic potential of umbilical cord mesenchymal stem cells in mice premature ovarian failure. BioMed Res Int 2013; 2013: 690491.
[http://dx.doi.org/10.1155/2013/690491] [PMID: 23998127]
[26]
Song D, Zhong Y, Qian C, et al. Human umbilical cord mesenchymal stem cells therapy in cyclophosphamide-induced premature ovarian failure rat model. BioMed Res Int 2016; 2016: 2517514.
[http://dx.doi.org/10.1155/2016/2517514] [PMID: 27047962]
[27]
Elfayomy AK, Almasry SM, El-Tarhouny SA, Eldomiaty MA. Human umbilical cord blood-mesenchymal stem cells transplantation renovates the ovarian surface epithelium in a rat model of premature ovarian failure: Possible direct and indirect effects. Tissue Cell 2016; 48(4): 370-82.
[http://dx.doi.org/10.1016/j.tice.2016.05.001] [PMID: 27233913]
[28]
Goswami D, Conway GS. Premature ovarian failure. Hum Reprod Update 2005; 11(4): 391-410.
[http://dx.doi.org/10.1093/humupd/dmi012] [PMID: 15919682]
[29]
Helden JV, Weiskirchen R. Age-independent anti-Müllerian hormone (AMH) standard deviation scores to estimate ovarian function. Eur J Obstet Gynecol Reprod Biol 2017; 213: 64-70.
[http://dx.doi.org/10.1016/j.ejogrb.2017.04.029] [PMID: 28437631]
[30]
Khedr NF. Protective effect of mirtazapine and hesperidin on cyclophosphamide-induced oxidative damage and infertility in rat ovaries. Exp Biol Med (Maywood) 2015; 240(12): 1682-9.
[http://dx.doi.org/10.1177/1535370215576304] [PMID: 25787947]

Rights & Permissions Print Cite
Article Metrics
22
1
© 2024 Bentham Science Publishers | Privacy Policy